OverviewSuggest Edit

Invitae is a company engaged in medical genetic testing. It specializes in genetic diagnostics for hereditary disorders. The company offers genetic tests in various clinical areas including hereditary cancer, cardiology, neurology, pediatrics, metabolic conditions, and rare diseases, as well as prenatal and perinatal genetic tests.

TypePublic
Founded2010
HQSan Francisco, CA, US
Websiteinvitae.com
Employee Ratings3.8
Overall CultureA+

Latest Updates

Employees (est.) (Dec 2019)1,300(+65%)
Revenue (FY, 2019)$216.8 M(+47%)
Share Price (Feb 2021)$50.8 (+3%)
Cybersecurity ratingCMore

Key People/Management at Invitae

Sean George

Sean George

Chief Executive Officer and Co-Founder
Michele Cargill

Michele Cargill

Co-Founder, Key Projects and Advisor to the CEO
Lee Bendekgey

Lee Bendekgey

Chief Policy Officer
Robbie Evans

Robbie Evans

Chief Strategy Officer
Sandra Close

Sandra Close

Chief Diagnostic Strategy Officer
Tom Brida

Tom Brida

General Counsel, Chief Compliance Officer and Secretary
Show more

Invitae Office Locations

Invitae has an office in San Francisco
San Francisco, CA, US (HQ)
1400 16th St, San Francisco
Show all (1)

Invitae Financials and Metrics

Invitae Revenue

Embed Graph
View revenue for all periods
Invitae's revenue was reported to be $216.82 m in FY, 2019 which is a 46.8% increase from the previous period.
USD

Revenue (Q3, 2020)

68.7m

Gross profit (Q3, 2020)

22.1m

Gross profit margin (Q3, 2020), %

32.1%

Net income (Q3, 2020)

(102.9m)

EBIT (Q3, 2020)

(80.8m)

Market capitalization (8-Feb-2021)

9.7b

Closing stock price (8-Feb-2021)

50.8

Cash (30-Sept-2020)

106.4m

EV

9.9b
Invitae's current market capitalization is $9.7 b.
Annual
USDFY, 2017FY, 2018FY, 2019

Revenue

68.2m147.7m216.8m

Revenue growth, %

117%47%

Cost of goods sold

50.1m80.1m118.1m

Gross profit

18.1m67.6m98.7m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Revenue

27.7m37.3m37.4m40.6m53.5m56.5m64.2m46.2m68.7m

Cost of goods sold

18.1m20.4m20.4m21.3m28.0m32.1m40.4m43.0m46.6m

Gross profit

9.6m16.9m16.9m19.3m25.5m24.4m23.8m3.2m22.1m

Gross profit Margin, %

35%45%45%48%48%43%37%7%32%
Annual
USDFY, 2017FY, 2018FY, 2019

Cash

12.1m112.2m151.4m

Accounts Receivable

10.4m26.3m32.5m

Prepaid Expenses

11.6m13.3m18.0m

Current Assets

86.7m165.4m442.4m
Quarterly
Annual
USDFY, 2017FY, 2018FY, 2019

Net Income

(123.4m)(129.4m)(242.0m)

Depreciation and Amortization

9.2m13.5m16.2m

Accounts Payable

(535.0k)(417.0k)1.6m

Cash From Operating Activities

(98.0m)(92.2m)(145.1m)
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020

Net Income

(36.1m)(67.8m)(99.5m)(37.7m)(86.4m)(165.1m)(98.5m)(264.9m)(367.8m)

Depreciation and Amortization

3.4m6.9m10.3m3.3m6.7m11.1m6.1m14.5m23.0m

Accounts Payable

(1.6m)(3.1m)(1.2m)(307.0k)(4.0m)87.0k13.1m9.2m3.1m

Cash From Operating Activities

(32.9m)(58.7m)(76.7m)(28.4m)(61.1m)(97.8m)(62.4m)(122.8m)(184.9m)
USDFY, 2017

Revenue/Employee

114.9k

Debt/Equity

0.4 x

Debt/Assets

0.2 x

Financial Leverage

1.7 x
Show all financial metrics

Invitae Operating Metrics

FY, 2017Q1, 2018Q2, 2018Q3, 2018FY, 2018Q1, 2019Q2, 2019Q3, 2019FY, 2019Q1, 2020Q2, 2020

Billable Tests Generated

145 k59 k73 k75 k292 k87 k111 k124 k469 k151 k113 k

Average Revenue per Test

$449 $459 $500 $490 $495 $455 $471 $448 $453 $418 $399

Samples Accessioned

150 k64 k73 k78 k303 k94 k111 k129 k482 k154 k120 k

Cost per Sample Accessioned

$335 $279 $279 $262 $264 $226 $252 $249 $245 $262 $358
Show all operating metrics

Invitae Acquisitions / Subsidiaries

Company NameDateDeal Size
DiploidMarch 10, 2020$95 m
GenelexMarch 10, 2020$20.70 m
YouScriptMarch 10, 2020$79.30 m
Clear GeneticsNovember 11, 2019
JunglaJuly 11, 2019$50 m
Singular BioJune 20, 2019$55 m
CombiMatrixNovember 15, 2017$33 m
Good Start GeneticsJuly 31, 2017$24.30 m
CancerGene ConnectJune 12, 2017
Clear Genetics, Inc.
Show more

Invitae Revenue Breakdown

Embed Graph

Invitae revenue breakdown by business segment: 98.0% from Test Revenue and 2.0% from Other

Invitae revenue breakdown by geographic segment: 93.4% from United States and 6.6% from Other

Invitae Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

Invitae Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Invitae Online and Social Media Presence

Embed Graph

Invitae Company Culture

  • Overall Culture

    A+

    94/100

  • CEO Rating

    A+

    95/100

  • Compensation

    A+

    100/100

Learn more on Comparably

Invitae News and Updates

Invitae to Announce Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 17, 2021

SAN FRANCISCO, Feb. 3, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that it will report its fourth quarter and full year 2020 financial results on Wednesday, February 17, 2021 and will host a conference call and webcast that...

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

SAN FRANCISCO, Jan. 14, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced the launch of a new project with Bristol Myers Squibb, Janssen Research & Development, LLC (Janssen), Novartis and Genentech, a member of the Roche Group, to...

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

New platform expected to make whole genome sequencing significantly more affordable and accessible for use in mainstream medical care New platform expected to make whole genome sequencing significantly more affordable and accessible for use in mainstream medical care

Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume

SAN FRANCISCO, Jan. 11, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, announced preliminary unaudited full-year 2020 results, reporting strong growth in volume and revenue, signaling continued momentum into 2021. "We are very pleased by the...

Invitae to Present at the 39th Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO, Dec. 29, 2020 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12,...

Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses Faster

SAN FRANCISCO, Dec. 17, 2020 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced all patients who undergo exome testing with Invitae will receive routine case-level reanalysis of their findings every six months for at least three years. Reanalysis...
Show more

Invitae Blogs

How Invitae detects challenging genotypes - Dianalee McKnight, PhD, FACMG

Modern genetic sequencing is driven by a fast and cost-effective DNA technology called next-generation sequencing (NGS). This powerful tool is used by many clinical labs to give timely answers to patients with medical genetic concerns. But there are some facets of our genome—like pseudogenes, repeti…

Seeing patients from home (and staying HIPAA-compliant): A guide for GCs - By: Kate Lynch MS, CGC, Rachel Riesgraf MS, CGC, and RJ Okamura MS, CGC

If you’re reading this, you may have found yourself at home in your PJs, surrounded by dirty dishes, and utterly confused as to how you’re supposed to juggle home demands with work demands—and stay HIPAA-compliant in the process.  Believe it or not, it is possible to have a productive—and compliant—…

Genetics Insider: March 2020

We are working to provide continuity of care during the developing COVID-19 situation. Please click here to learn how we are supporting you and your patients. Literature reviewDid you catch what our colleagues are doing? Update on genetic causes of long QT syndrome In response to recent changes in o…

Looking back and moving forward: What’s next for lysosomal storage disorders

Britt Johnson Ph.D., FACMG, Medical Director of Metabolic Genetics As the 16th annual WORLDSymposium on lysosomal storage disorders (LSDs) is this week, I find myself reflecting on the many advancements that have been made since I started my first clinical genetics fellowship just 10 years ago.  I a…

World Cancer Day: The importance of germline genetic testing in prostate cancer - By Sarah Nielsen, MS, LCGC

As a healthcare provider, you already know how prevalent and burdensome prostate cancer is on patients and their families. Although the cause of this common, deadly cancer still remains unclear in many men and its etiology continues to be explored. It is now recognized as more than just an inevitabl…

Automating the translation of science to continually improve genetic tests

Alexandre Colavin was recently announced as a winner of the 2019 Innovator Under 35 Europe award by MIT Technology Review in recognition of his work to improve variant interpretation for genetic testing. In this post, Alex recounts the motivation and challenges of translating his research and some n…
Show more

Invitae Frequently Asked Questions

  • When was Invitae founded?

    Invitae was founded in 2010.

  • Who are Invitae key executives?

    Invitae's key executives are Sean George, Michele Cargill and Lee Bendekgey.

  • How many employees does Invitae have?

    Invitae has 1,300 employees.

  • What is Invitae revenue?

    Latest Invitae annual revenue is $216.8 m.

  • What is Invitae revenue per employee?

    Latest Invitae revenue per employee is $166.8 k.

  • Who are Invitae competitors?

    Competitors of Invitae include Natera, Quest Diagnostics and Bio-Reference Laboratories.

  • Where is Invitae headquarters?

    Invitae headquarters is located at 1400 16th St, San Francisco, San Francisco.

  • Where are Invitae offices?

    Invitae has an office in San Francisco.

  • How many offices does Invitae have?

    Invitae has 1 office.